Literature DB >> 33146403

Down-regulation of miR-215 attenuates lipopolysaccharide-induced inflammatory injury in CCD-18co cells by targeting GDF11 through the TLR4/NF-kB and JNK/p38 signaling pathways.

Boyang Sun1,2, Kai Xing3, Chen Qi4, Ke Yan1,2, Yan Xu2,5.   

Abstract

Ulcerative colitis (UC) is a risk factor for carcinogenesis of colorectal cancer, which is associated with disruption of the epithelial barrier and disorder of the inflammatory response. It has been reported that the expression of microRNA (miR)-215 is upregulated in patients with long-term UC. The present study aimed to investigate the effects of miR-215 on lipopolysaccharide (LPS)-induced inflammatory injury in CCD-18Co cells, as well as to identify the underlying possible molecular mechanisms. CCD-18Co cells were treated with 1 µg/ml LPS to induce inflammatory injury. Reverse transcription-quantitative PCR was performed to determine the expression of miR-215 in LPS-treated CCD-18Co cells. Moreover, a dual luciferase reporter system assay was used to evaluate the interaction of miR-215 and growth differentiation factor 11 (GDF11) in CCD-18Co cells. The expression of miR-215 was significantly upregulated in LPS-treated CCD-18Co cells. Knockdown of miR-215 significantly alleviated the inflammatory response and oxidative stress in LPS-treated CCD-18Co cells. In addition, GDF11 was identified as a direct binding target of miR-215 in CCD-18Co cells. Knockdown of miR-215 significantly increased the expression of GDF11, but decreased the expression levels of Toll-like receptor (TLR)4, phosphorylated (p)-p65, iNOS, p-p38 and p-JNK in LPS-treated CCD-18Co cells. Collectively, the present findings indicated that knockdown of miR-215 alleviated oxidative stress and inflammatory response in LPS-treated CCD-18Co cells by upregulating GDF11 expression and inactivating the TLR4/NF-κB and JNK/p38 signaling pathways.

Entities:  

Year:  2020        PMID: 33146403     DOI: 10.14670/HH-18-278

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  42 in total

Review 1.  AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Authors:  Francis A Farraye; Robert D Odze; Jayne Eaden; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2010-02       Impact factor: 22.682

2.  Altered miRNAs expression profiles and modulation of immune response genes and proteins during neonatal sepsis.

Authors:  Jiande Chen; Siyuan Jiang; Yun Cao; Yi Yang
Journal:  J Clin Immunol       Date:  2014-02-28       Impact factor: 8.317

3.  Downregulation of MicroRNA-21 in Colonic CD3+ T Cells in UC Remission.

Authors:  Yugo Ando; Luca Mazzurana; Marianne Forkel; Kazuichi Okazaki; Mamiko Aoi; Peter T Schmidt; Jenny Mjösberg; Francesca Bresso
Journal:  Inflamm Bowel Dis       Date:  2016-12       Impact factor: 5.325

4.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.

Authors:  Muller Fabbri; Alessio Paone; Federica Calore; Roberta Galli; Eugenio Gaudio; Ramasamy Santhanam; Francesca Lovat; Paolo Fadda; Charlene Mao; Gerard J Nuovo; Nicola Zanesi; Melissa Crawford; Gulcin H Ozer; Dorothee Wernicke; Hansjuerg Alder; Michael A Caligiuri; Patrick Nana-Sinkam; Danilo Perrotti; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 5.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

6.  Andrographolide derivative CX-10 ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Involvement of NF-κB and MAPK signalling pathways.

Authors:  Zhenfang Gao; Cuicui Yu; Haiyue Liang; Xuekai Wang; Yue Liu; Xin Li; Kai Ji; Hui Xu; Mingyan Yang; Ke Liu; Dong Qi; Huaying Fan
Journal:  Int Immunopharmacol       Date:  2018-02-22       Impact factor: 4.932

7.  Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease.

Authors:  Liping Chen; Wei Wang; Rui Zhou; Siew C Ng; Jin Li; Meifang Huang; Feng Zhou; Xin Wang; Bo Shen; Michael A Kamm; Kaichun Wu; Bing Xia
Journal:  Medicine (Baltimore)       Date:  2014-08       Impact factor: 1.889

8.  miR-215 suppresses proliferation and migration of non-small cell lung cancer cells.

Authors:  Xiaopan Cai; Dongyu Peng; Haifeng Wei; Xinghai Yang; Quan Huang; Zaijun Lin; Wei Xu; Ming Qian; Cheng Yang; Tielong Liu; Wangjun Yan; Jian Zhao
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

9.  miRNA-215-5p suppresses the aggressiveness of breast cancer cells by targeting Sox9.

Authors:  Jia Bao Gao; Ming Nan Zhu; Xiao Liang Zhu
Journal:  FEBS Open Bio       Date:  2019-10-22       Impact factor: 2.693

10.  Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα.

Authors:  Xiao Feng; Hao Wang; Shicai Ye; Jiaxi Guan; Wenkai Tan; Si Cheng; Guoli Wei; Weiyun Wu; Feng Wu; Yu Zhou
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more
  1 in total

Review 1.  Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models.

Authors:  Sophie Vieujean; Bénédicte Caron; Vincent Haghnejad; Jean-Yves Jouzeau; Patrick Netter; Anne-Charlotte Heba; Ndeye Coumba Ndiaye; David Moulin; Guillermo Barreto; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Int J Mol Sci       Date:  2022-07-09       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.